| Baseline human gut microbiota profile in healthy people and standard reporting template CH King, H Desai, AC Sylvetsky, J LoTempio, S Ayanyan, J Carrie, ... PloS one 14 (9), e0206484, 2019 | 186 | 2019 |
| Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B. S Rao, SY Lee, A Gutierrez, J Perrigoue, RJ Thapa, Z Tu, JR Jeffers, ... Blood, 2012 | 165 | 2012 |
| A pan-cancer analysis reveals high-frequency genetic alterations in mediators of signaling by the TGF-β superfamily A Korkut, S Zaidi, RS Kanchi, S Rao, NR Gough, A Schultz, X Li, ... Cell systems 7 (4), 422-437. e7, 2018 | 143 | 2018 |
| Recent developments and therapeutic strategies against hepatocellular carcinoma M Yarchoan, P Agarwal, A Villanueva, S Rao, LA Dawson, T Karasic, ... Cancer research 79 (17), 4326-4330, 2019 | 128 | 2019 |
| The ribosomal protein Rpl22 controls ribosome composition by directly repressing expression of its own paralog, Rpl22l1. KBK O'Leary MN1, Schreiber KH, Zhang Y, Duc AC, Rao S, Hale JS, Academia EC ... PLoS Genet 9 (8), 2013 | 125 | 2013 |
| Analysis of genomes and transcriptomes of hepatocellular carcinomas identifies mutations and gene expression changes in the transforming growth factor-β pathway J Chen, S Zaidi, S Rao, JS Chen, L Phan, P Farci, X Su, K Shetty, J White, ... Gastroenterology 154 (1), 195-210, 2018 | 122 | 2018 |
| Gambogic acid mediates apoptosis as a p53 inducer through down-regulation of mdm2 in wild-type p53-expressing cancer cells H Gu, X Wang, S Rao, J Wang, J Zhao, FL Ren, R Mu, Y Yang, Q Qi, ... Molecular cancer therapeutics 7 (10), 3298-3305, 2008 | 100 | 2008 |
| Control of hematopoietic stem cell emergence by antagonistic functions of ribosomal protein paralogs. WDL Zhang Y, Duc AC, Rao S, Sun XL, Bilbee AN, Rhodes M, Li Q, Kappes DJ ... Dev Cell. 24 (4), 411-25., 2013 | 99 | 2013 |
| Gambogic acid reduced bcl-2 expression via p53 in human breast MCF-7 cancer cells H Gu, S Rao, J Zhao, J Wang, R Mu, J Rong, L Tao, Q Qi, Q You, Q Guo Journal of cancer research and clinical oncology 135, 1777-1782, 2009 | 88 | 2009 |
| Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer LS Lyons, S Rao, W Balkan, J Faysal, CA Maiorino, KL Burnstein Molecular endocrinology 22 (3), 597-608, 2008 | 72 | 2008 |
| A novel nuclear role for the Vav3 nucleotide exchange factor in androgen receptor coactivation in prostate cancer S Rao, LS Lyons, CD Fahrenholtz, F Wu, A Farooq, W Balkan, ... Oncogene 31 (6), 716-727, 2012 | 52 | 2012 |
| Mutated CEACAMs disrupt transforming growth factor beta signaling and alter the intestinal microbiome to promote colorectal carcinogenesis S Gu, S Zaidi, MI Hassan, T Mohammad, TM Malta, H Noushmehr, ... Gastroenterology 158 (1), 238-252, 2020 | 49 | 2020 |
| Transforming growth factor‐β in liver cancer stem cells and regeneration S Rao, S Zaidi, J Banerjee, W Jogunoori, R Sebastian, B Mishra, ... Hepatology communications 1 (6), 477-493, 2017 | 42 | 2017 |
| Plant stress responses mediated by CBL–CIPK phosphorylation network SK Sanyal, S Rao, LK Mishra, M Sharma, GK Pandey The enzymes 40, 31-64, 2016 | 37 | 2016 |
| Novel interaction between the co-chaperone Cdc37 and Rho GTPase exchange factor Vav3 promotes androgen receptor activity and prostate cancer growth F Wu, SO Peacock, S Rao, SK Lemmon, KL Burnstein Journal of biological chemistry 288 (8), 5463-5474, 2013 | 32 | 2013 |
| Ribosomal protein Rpl22 controls the dissemination of T-cell lymphoma S Rao, KQ Cai, JE Stadanlick, N Greenberg-Kushnir, N Solanki-Patel, ... Cancer research 76 (11), 3387-3396, 2016 | 30 | 2016 |
| RPL22L1 induction in colorectal cancer is associated with poor prognosis and 5-FU resistance S Rao, S Peri, J Hoffmann, KQ Cai, B Harris, M Rhodes, DC Connolly, ... PLoS One 14 (10), e0222392, 2019 | 27 | 2019 |
| Comparative studies on hepatic protective and choleretic effect of geniposide and crocetin J Peng, ZY Qian, TZ Liu, SY Rao, B Qu Chinese Journal of New Drugs 12 (2), 105-108, 2003 | 23 | 2003 |
| β2-spectrin (SPTBN1) as a therapeutic target for diet-induced liver disease and preventing cancer development S Rao, X Yang, K Ohshiro, S Zaidi, Z Wang, K Shetty, X Xiang, MI Hassan, ... Science translational medicine 13 (624), eabk2267, 2021 | 22 | 2021 |
| Targeting transforming growth factor beta signaling in liver cancer S Rao, L Mishra Hepatology 69 (4), 1375-1378, 2019 | 19 | 2019 |
